{
    "Project Title": "A Randomized Multicenter Phase II Study Using 2-1[Hexyloxyethyl]-2-Devinylpyropheophorbide-A (HPPH) with PDT versus Standard of Care Surgery for Patients with T1/T2 N0 Squamous Cell Carcinoma of the Oral Cavity",
    "Sponsor": "Roswell Park Cancer Institute",
    "Study Number": "I 33616",
    "Protocol Version and Date": "Not Available",
    "Study Title": "A Randomized Multicenter Phase II Study Using 2-1[Hexyloxyethyl]-2-Devinylpyropheophorbide-A (HPPH) with PDT versus Standard of Care Surgery for Patients with T1/T2 N0 Squamous Cell Carcinoma of the Oral Cavity",
    "Phase": "Phase II",
    "Therapeutic Area": "Oral Cavity Cancer",
    "Number of Patients": "114",
    "Number of Sites": "3",
    "Indication": "T1/T2 N0 Squamous Cell Carcinoma of the Oral Cavity",
    "Duration of Treatment": "Not Available",
    "Schedule of Assessments": "Not Available",
    "questionnaires": [
        {
            "longName": "Performance Status (ECOG)",
            "shortName": "ECOG",
            "type": "ClinRO",
            "questionnaireSchedule": "Baseline, Day 0, Day 1, Week 1, 4-6 weeks, 12-16 weeks",
            "questionnaireTiming": [
                "Baseline1",
                "~12-16 Weeks Post Treatment",
                "Follow-Up2",
                "About 12-16 W Post Surgery"
            ]
        },
        {
            "longName": "Quality of Life Questionnaire",
            "shortName": "QoL",
            "type": "PRO",
            "questionnaireSchedule": "Baseline, 12-16 weeks, 6, 12, 18, and 24 months",
            "questionnaireTiming": [
                "Baseline1",
                "~12-16 Weeks Post Treatment",
                "About 12-16 W Post Surgery"
            ]
        },
        {
            "longName": "Normal Tissue Toxicity Grade",
            "shortName": "Toxicity",
            "type": "ClinRO",
            "questionnaireSchedule": "Day 0, Day 1, 2 weeks",
            "questionnaireTiming": [
                "Day 1 Treatment",
                "~1 Week Post Treatment",
                "~4-6 Weeks Post Treatment",
                "About 1 Week Post Surgery",
                "About  4-6 W  Post Surgery"
            ]
        },
        {
            "longName": "Clinical Examination",
            "shortName": "Exam",
            "type": "ClinRO",
            "questionnaireSchedule": "Baseline, Day 0, Day 1, Week 1, 4-6 weeks, 12-16 weeks",
            "questionnaireTiming": [
                "Baseline1",
                "~1 Week Post Treatment",
                "~4-6 Weeks Post Treatment",
                "~12-16 Weeks Post Treatment",
                "Follow-Up2",
                "About 1 Week Post Surgery",
                "About  4-6 W  Post Surgery",
                "About 12-16 W Post Surgery"
            ]
        },
        {
            "longName": "Response Clinical Evaluation",
            "shortName": "Response Clinical",
            "type": "ClinRO",
            "questionnaireSchedule": "At each follow-up visit and at 2 years",
            "questionnaireTiming": [
                "Baseline1",
                "~12-16 Weeks Post Treatment",
                "Follow-Up2",
                "About 12-16 W Post Surgery"
            ]
        },
        {
            "longName": "Response Pathological Evaluation",
            "shortName": "Response Pathological",
            "type": "ClinRO",
            "questionnaireSchedule": "At routine visits, only if clinically indicated",
            "questionnaireTiming": [
                "Baseline1",
                "~12-16 Weeks Post Treatment",
                "Follow-Up2",
                "About 12-16 W Post Surgery"
            ]
        }
    ]
}